Premium
OS Therapies Incorporated (OSTX)
AMEX
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Topline Data from Phase 2b clinical trial of OST-HER2 in Osteosarcoma expected to be released in December 2024 OS Therapies, Inc. (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a...
OS Therapies (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that Paul Romness, Chief...
OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, is pleased to invite investors to...
Concurrently, the Company accepted the resignations of Dr. Colin Goddard and Mr. Joacim Borg OS Therapies (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.13 | 60.4278074866 | 1.87 | 4.77 | 1.8248 | 130364 | 3.70259323 | CS |
| 4 | 0.63 | 26.582278481 | 2.37 | 4.77 | 1.58 | 56377 | 3.0135425 | CS |
| 12 | -0.5 | -14.2857142857 | 3.5 | 4.77 | 1.58 | 39769 | 2.97799549 | CS |
| 26 | -1 | -25 | 4 | 4.9 | 1.58 | 122391 | 3.656465 | CS |
| 52 | -1 | -25 | 4 | 4.9 | 1.58 | 122391 | 3.656465 | CS |
| 156 | -1 | -25 | 4 | 4.9 | 1.58 | 122391 | 3.656465 | CS |
| 260 | -1 | -25 | 4 | 4.9 | 1.58 | 122391 | 3.656465 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| MSTZT Rex 2X Inverse MSTR Daily Target ETF | US$ 0,841198 (-7,56%) | 947,99M |
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 30,70 (7,87%) | 103,68M |
| NVDQT Rex 2X Inverse NVIDIA Daily Target ETF | US$ 3,535 (4,59%) | 65,49M |
| SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 5,835 (0,43%) | 52,34M |
| SENSSenseonics Holdings Inc | US$ 0,46 (6,70%) | 51,61M |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
